Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.

van Baars R, Griffin H, Wu Z, Soneji YJ, van de Sandt M, Arora R, van der Marel J, Ter Harmsel B, Jach R, Okon K, Huras H, Jenkins D, Quint W, Doorbar J.

Am J Surg Pathol. 2015 Nov;39(11):1518-1528. doi: 10.1097/PAS.0000000000000498.

2.

CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies.

van Baars R, van der Marel J, Snijders PJ, Rodriquez-Manfredi A, ter Harmsel B, van den Munckhof HA, Ordi J, del Pino M, van de Sandt MM, Wentzensen N, Meijer CJ, Quint WG.

Int J Cancer. 2016 Jan 15;138(2):463-71. doi: 10.1002/ijc.29706. Epub 2015 Aug 14.

3.

The Value of Endocervical Curettage in Addition to Biopsies in Women Referred to Colposcopy.

van der Marel J, Rodriguez A, Del Pino M, van Baars R, Jenkins D, van de Sandt MM, Torné A, Ordi J, ter Harmsel B, Verheijen RH, Schiffman M, Gage JC, Quint WG, Wentzensen N.

J Low Genit Tract Dis. 2015 Oct;19(4):282-7. doi: 10.1097/LGT.0000000000000124.

PMID:
26083332
4.

Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.

Griffin H, Soneji Y, Van Baars R, Arora R, Jenkins D, van de Sandt M, Wu Z, Quint W, Jach R, Okon K, Huras H, Singer A, Doorbar J.

Mod Pathol. 2015 Jul;28(7):977-93. doi: 10.1038/modpathol.2015.52. Epub 2015 May 8.

5.

HPV genotyping among women treated for high-grade cervical intraepithelial neoplasia with no lesion in the conization specimen.

Rodríguez-Manfredi Á, van Baars R, Quint WG, Sanchez MJ, Torné A, Ordi J, Del Pino M.

Int J Gynaecol Obstet. 2015 May;129(2):109-13. doi: 10.1016/j.ijgo.2014.11.009. Epub 2015 Jan 16.

PMID:
25638710
6.

Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?

van der Marel J, Berkhof J, Ordi J, Torné A, Del Pino M, van Baars R, Schiffman M, Wentzensen N, Jenkins D, Quint WG.

Am J Surg Pathol. 2015 Apr;39(4):496-504. doi: 10.1097/PAS.0000000000000342.

PMID:
25353286
7.

The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy.

van der Marel J, van Baars R, Rodriguez A, Quint WG, van de Sandt MM, Berkhof J, Schiffman M, Torné A, Ordi J, Jenkins D, Verheijen RH, Helmerhorst TJ, Ter Harmsel B, Wentzensen N, Del Pino M.

Gynecol Oncol. 2014 Nov;135(2):201-7. doi: 10.1016/j.ygyno.2014.08.040. Epub 2014 Sep 7.

PMID:
25204846
8.

Oncogenic human papillomavirus-infected immature metaplastic cells and cervical neoplasia.

van der Marel J, van Baars R, Alonso I, del Pino M, van de Sandt M, Lindeman J, ter Harmsel B, Boon M, Smedts F, Ordi J, Torné A, Jenkins D, Quint W.

Am J Surg Pathol. 2014 Apr;38(4):470-9. doi: 10.1097/PAS.0000000000000174.

PMID:
24503756
9.

The impact of human papillomavirus genotype on colposcopic appearance: a cross-sectional analysis.

van der Marel J, van Baars R, Quint WG, Berkhof J, del Pino M, Torné A, Ordi J, Wentzensen N, Schiffman M, van de Sandt MM, Lindeman J, Jenkins D, Helmerhorst TJ, Verheijen RH, ter Harmsel B, Alonso I.

BJOG. 2014 Aug;121(9):1117-26. doi: 10.1111/1471-0528.12668. Epub 2014 Feb 4.

10.

Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge.

Geraets DT, van Baars R, Alonso I, Ordi J, Torné A, Melchers WJ, Meijer CJ, Quint WG.

J Clin Virol. 2013 Jun;57(2):125-9. doi: 10.1016/j.jcv.2013.02.016. Epub 2013 Mar 19.

PMID:
23518442
11.

Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn Brush, providing reliable human papillomavirus detection combined with comfort for women.

van Baars R, Bosgraaf RP, ter Harmsel BW, Melchers WJ, Quint WG, Bekkers RL.

J Clin Microbiol. 2012 Dec;50(12):3937-43. doi: 10.1128/JCM.01506-12. Epub 2012 Sep 26.

12.

Different DNA damage and cell cycle checkpoint control in low- and high-risk human papillomavirus infections of the vulva.

Santegoets LA, van Baars R, Terlou A, Heijmans-Antonissen C, Swagemakers SM, van der Spek PJ, Ewing PC, van Beurden M, van der Meijden WI, Helmerhorst TJ, Blok LJ.

Int J Cancer. 2012 Jun 15;130(12):2874-85. doi: 10.1002/ijc.26345. Epub 2011 Aug 30.

Supplemental Content

Loading ...
Support Center